s
Phagenesis, a medical device company specializing in the treatment of swallowing disorders, successfully closes a $42M Series D financing round led by EQT Life Sciences and Sectoral Asset Management
04-03-2024, 13:10
MANCHESTER, England, March 4, 2024 /PRNewswire/ — Phagenesis, a pioneering UK company which has developed a revolutionary neurostimulation system to treat swallowing dysfunction, has closed a $42M Series D financing all equity investment round. The combined European and United States investment syndicate was led by EQT Life Sciences, and co-led by Sectoral, with new investors […] L'articolo Phagenesis, a medical device company specializing in the treatment of swallowing disorders, successfully closes a $42M Series D financing round led by EQT Life Sciences and Sectoral Asset Management proviene da La Ragione.
CONTINUA A LEGGERE
7
0
0
Guarda anche
La Ragione
00:43
Regno Unito, per gli exit poll larga vittoria dei Laburisti
La Ragione
Ieri, 22:43
Meloni “Il premierato rafforza il potere dei cittadini”
La Ragione
Ieri, 22:43
Palermo, Monti “Passi avanti verso il nuovo waterfront”
La Ragione
Ieri, 21:43
Palermo, Lagalla “Prosegue sinergia con l’Autorità portuale”
La Ragione
Ieri, 20:43
Palermo, con la passeggiata di Sant’Erasmo nuovo tratto del waterfront
La Ragione
Ieri, 20:43